Enterobacter spp. high in stool: what results mean

Published October 7, 2026 · Updated October 19, 2026 · 5 min read

A high Enterobacter spp. stool result means the measured amount is above the laboratory’s reference interval. It does not, by itself, establish an infection or identify a treatment. The useful next step is to read the result alongside your symptoms, the test method and the rest of the report.

On this page

What is Enterobacter?

Enterobacter is a genus, or group of related bacteria. These bacteria are Gram-negative and can live in the intestinal community. “Spp.” means species within the genus; it is not the name of one particular strain. Enterobacter can also cause opportunistic infections, so the sample location and clinical setting matter. [6]

A small primary study recovered Enterobacter and other related bacteria from stool samples of healthy adults. This shows that carriage can occur without an active infection. It does not establish an ideal stool concentration, prove that every strain is harmless or validate a GI-MAP treatment threshold. [1]

Similar names, different meanings

  • Enterobacter spp.: a genus-level result, rather than an identification of every species present.
  • Enterobacter cloacae complex: a more specific group encountered in clinical microbiology. Do not assume that a general stool finding identifies it.
  • Enterobacter aerogenes: an older name for Klebsiella aerogenes. Older studies and current reports may use different names. [4]
  • Enterobacterales: a broader bacterial group that includes multiple genera. It is not interchangeable with Enterobacter.
  • Enterococcus: a different genus, despite the similar spelling.

What does the GI-MAP Enterobacter result measure?

GI-MAP uses quantitative PCR, or qPCR, to measure microbial DNA targets in stool. Its Enterobacter spp. line is a targeted group measurement. The manufacturer’s guide describes reporting amounts using scientific notation and units per gram of stool. Read the units and reference interval on your own report. [2]

A DNA measurement is different from growing live organisms in a culture. The Enterobacter amount alone does not establish which strain is present, whether it is causing symptoms or which antibiotic would work. The opportunistic-bacteria guide explains how a report category differs from an infection diagnosis.

A simple example of reading the number

If a report displays 2.0e8, that notation means 2.0 × 108, or 200 million, in the stated units. This is an arithmetic example, not a normal range or a treatment cutoff. Check the unit, comparator and flag together. A number per gram is not a percentage of all your gut bacteria, and a larger number is not automatically a measure of disease severity.

What do high, low and normal results mean?

Enterobacter spp. high in stool

A high flag describes the comparison with that laboratory’s interval. It does not explain why the amount is higher or establish that Enterobacter caused your symptoms. In particular, this stool result alone does not diagnose a urinary infection or bloodstream infection: those are different clinical questions involving different sample sites.

Research linking a bacterial group with a condition is not a diagnostic rule for an individual. The international consensus on microbiome testing emphasizes that evidence for broad clinical use remains limited. Avoid turning a single composition finding into a diagnosis or a personalized treatment plan. [3]

Enterobacter spp. low in stool

A low or undetected result does not establish a deficiency that must be corrected with a probiotic. A genus-level amount does not directly measure the health of your gut lining. Before trying to raise a number, ask what clinical benefit that change would be expected to produce and what evidence supports it.

A result within the interval

A result within the printed interval answers only that comparison. It does not explain persistent digestive symptoms or exclude every gastrointestinal condition. Likewise, an isolated high result should not displace a careful assessment of symptoms, history and other relevant findings.

How to discuss the result with your clinician

Bring the full report, its collection date, a symptom timeline and a list of medicines and supplements. Useful questions include:

  • Does this finding help explain my symptoms, or could it be incidental?
  • What other causes should we consider before acting on this number?
  • Would a different test answer a specific clinical question?
  • If treatment or repeat testing is proposed, what outcome would show that it helped?

If a clinician suspects an actual bacterial infection, the investigation may need a sample from the affected site and laboratory susceptibility testing. IDSA guidance distinguishes colonization from infection and bases antimicrobial selection on the causative organism and relevant susceptibility evidence. Do not choose antibiotics or an antimicrobial “cleansing” regimen from a stool abundance flag. [4]

Common questions

Does high Enterobacter mean I have SIBO or a histamine problem?

No diagnosis follows from this result alone. A stool measurement does not locate bacterial growth in the small intestine or measure histamine production. Discuss those symptoms as separate clinical questions rather than assuming the Enterobacter number answers them.

Does this mean carbapenem-resistant Enterobacterales (CRE)?

No. CRE refers to Enterobacterales resistant to carbapenem antibiotics. The Enterobacter name or amount in stool does not establish that resistance. CDC also distinguishes colonization from infection; a person can carry CRE without an infection. A suspected resistant infection needs its own clinical assessment. [5]

Is Enterobacter the same as Enterococcus?

No. They are different genera. Check the exact row on your report before reading advice about either organism. See the Enterococcus guide for that separate result.

Can I compare results from different stool tests?

First compare the measured target, method, units and reference intervals. Similar labels do not guarantee equivalent measurements. Ask the laboratory or your clinician whether a change between reports is interpretable before treating it as an improvement or deterioration.

Sources and review

Sources checked October 19, 2026. Manufacturer material supports method descriptions; clinical guidance and research support interpretation limits. This article has not received medical review.

  1. Enterobacterales isolated from healthy subjects: primary study (2020). Small carriage study; not a GI-MAP validation study.
  2. Diagnostic Solutions Laboratory: GI-MAP interpretive guide (2025). Manufacturer method and target descriptions.
  3. International consensus statement on microbiome testing in clinical practice (2025). General clinical-utility limitations.
  4. IDSA guidance on antimicrobial-resistant Gram-negative infections (2026). Infection assessment, susceptibility and current nomenclature.
  5. CDC: About carbapenem-resistant Enterobacterales. Resistance and colonization explained.
  6. Public Health Agency of Canada: Enterobacter spp. pathogen safety data sheet. Basic organism characteristics; not used for current treatment advice.

This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.